This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Columbia Laboratories, Cardionet: Early Volume Plays

Stocks in this article: CBRXBEAT

NEW YORK ( TheStreet) -- Columbia Laboratories (CBRX) was among several stocks trading near $5 were poised to move on above-average volume Tuesday after the company announced a new loan.

Columbia Laboratories said it has signed a $15 million subordinated term loan with Watson Pharmaceuticals (WPI). Proceeds from the loan will be used to finance activities related to the company's PROCHIEVE 8% progesterone gel and related study, other development programs for preterm birth indication and other general corporate purposes.

Columbia Laboratories shares jumped by 14 cents, or 13.3%, to $1.19 in the premarket session. The 50-day average daily volume for Columbia Laboratories is 290,000, according to the Nasdaq.

Oncolytics Biotech (ONCY) rallied by 23 cents, or 7.9%, to $3.17 in the premarket session after the company said it has received approval from Belgium Federal Agency for Medicines and Health Products to conduct a Phase 3 Trial for REOLYSIN in patients with platinum-refractory head and neck cancers. The 50-day average daily volume for Oncolytics Biotech is 100,000.

Orexigen Therapeutics (OREX) rose by 30 cents, or 5.5%, to $5.74 in the premarket session after the company announces Food and Drug Administration acceptance of its Contrave new drug application for the treatment of obesity. The 50-day average daily volume for Orexigen Therapeutics is 666,000.

On the other hand, Cardionet (BEAT) slumped by 45 cents, or 5.8%, to $7.27 in the premarket session after Citigroup downgraded the stock to sell from hold. The 50-day average daily volume for Cardionet is 444,000.

-- Written by Robert Holmes in Boston.

Check out all of Tuesday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,614.81 +215.14 1.31%
S&P 500 1,941.28 +37.27 1.96%
NASDAQ 4,419.4780 +103.4040 2.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs